“AZD1222”: Serious Side Effect – AstraZeneca Stops Vaccine Trial



[ad_1]

Sciences “AZD1222”

Serious side effect: AstraZeneca stops vaccine testing

| Reading time: 2 minutes

An AstraZeneca laboratory.  The researchers now want to clarify whether the test subject's health problems were caused by the vaccine. An AstraZeneca laboratory.  The researchers now want to clarify whether the test subject's health problems were caused by the vaccine.

An AstraZeneca laboratory. The researchers now want to clarify whether the test subject’s health problems were caused by the vaccine.

What: REUTERS

The AstraZeneca vaccine is in the pivotal study phase with tens of thousands of participants and is considered great hope. But now the drug company has to stop testing. Apparently a test person is seriously ill.

reThe pharmaceutical company AstraZeneca stopped the clinical study of its corona vaccine after a serious side effect appeared to occur in one participant. This is a routine measure for such cases, the British company announced Wednesday night.

Now it is a question of clarifying whether the health problems were caused by the vaccine. During the arrest, no more study participants should be vaccinated and people who have been vaccinated should continue to be observed.

Unspecified health problems are an isolated case, the company stressed. The STAT news website first reported on the suspension of the study. A test person in the UK was ill, he said.

also read

World map and vaccine

The experimental vaccine known as “AZD1222” is currently in the third and final phase of the study with tens of thousands of participants and is considered one of the main candidates in the development of an effective vaccine against the new coronavirus.

Political pressure in the US

also read

Brand history Single planet

monitor

AstraZeneca and eight other pharmaceutical and biotech companies had only given guarantees Tuesday that they would not compromise safety by developing a corona vaccine. This unusual move came in light of concerns that there could be political pressure, especially in the US, to urgently approve the first vaccines before the November 3 presidential election.

The president of the United States, Donald Trump, promises almost daily that there will be a vaccine by the end of the year or possibly by the time of the elections.

[ad_2]